A step-by-step protocol from Dana-Farber Cancer Institute, Harvard Medical School and IQ Proteomics for measuring tyrosine phosphorylation in growth factor-stimulated, drug-treated cancer cells. Because tyrosine accounts for only about 2% of protein phosphorylation, the workflow enriches phosphopeptides by IMAC, labels samples with TMT for multiplexed quantification, then isolates phosphotyrosine peptides with an antibody before mass spectrometry, giving a reproducible, proteome-wide view of receptor tyrosine kinase signaling. The method was validated in a 2021 eLife study of SHP2-dependent signaling.
Enrichment of Tyrosine Phosphorylated Peptides for Quantitative Mass Spectrometry Analysis of RTK Signaling Dynamics
Vemulapalli V, Blacklow SC, Gygi SP, Erickson AR
PTM proteomics
IQP co-authored